Release Date: 19/02/18 11:13 Summary: T/overs Panel: SMC - 02R & 03R - Interim Orders Price Sensitive: Yes Download Document 128.02KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%